Advanced Therapies

#Advanced Therapies #Cell and gene therapy #Drug discovery #Webinar

DDW webinar: Achieve future success in cell and gene therapy

Hosted by DDW and sponsored by Astrea Bioseparations “Cell and gene therapies – how can market growth be sustained to maximise on opportunities” – will be free to attend on 28 February at 7AM PST / 10AM EST / 3PM GMT / 4PM CET.  … Read More

#News

#Advanced Therapies

eBook: Gene editing & CRISPR: Advances in applications and opportunity

This 24-page eBook sponsored by Scale Biosciences explores the latest innovations in gene editing and CRISPR, the possibilities of new editing techniques and where the greatest potential for the technology might lie in the future. Download this exclusive eBook to learn more about:   How CRISPR is providing new solutions for… Read More

#DDW eBooks

#Advanced Therapies #Cell and gene therapy #Drug discovery #Webinar

DDW webinar: Global opportunities in cell and gene therapy

Hosted by DDW and sponsored by Astrea Bioseparations “Cell and gene therapies – how can market growth be sustained to maximise on opportunities” – will be free to attend on 28 February at 7AM PST / 10AM EST / 3PM GMT / 4PM CET.  … Read More

#News

UK Department of Education
#Advanced Therapies #Cell and gene therapy #Cell and Gene Therapy Catapult #UK government

UK’s Education Secretary joins CGT Catapult to celebrate apprentices 

The UK’s Education Secretary Gillian Keegan attended a meeting with the Cell and Gene Therapy Catapult (CGT Catapult) to discuss the role of apprenticeships in the advanced therapies industry.  The meeting, which took place at Teesside University’s National Horizons Centre in Darlington during National Apprenticeship Week, highlighted… Read More

#News #Regulatory

Cell and gene therapy
#Advanced Therapies #Cell and gene therapy #Drug discovery #Gene therapy #Webinar

Cell & gene therapies: How can market growth be sustained to maximise on opportunities?

In this on-demand webinar, hosted by DDW and sponsored by Astrea Bioseparations, learn about how market growth can be sustained to maximise on opportunities in cell and gene therapy (CGT). You will hear from Doug Danison, Head of Commercial Strategy and Operations for Bayer CGT, Mark Treherne, Commercial Research Scientist… Read More

Webinar date:
Sponsored by Astrea Bioseparations
#Webinars

Cell and gene therapy concept
#Advanced Therapies #Cell and gene therapy #Drug discovery #Webinar

Cell and gene therapy market: Hear from the experts

Hosted by DDW and sponsored by Astrea Bioseparations “Cell and gene therapies – how can market growth be sustained to maximise on opportunities” – will be free to attend on 28 February at 7AM PST / 10AM EST / 3PM GMT / 4PM CET.   Join this… Read More

#News

Cell and gene therapy concept
#Advanced Therapies #Cell and gene therapy #Drug discovery #Webinar

Register now: Cell and gene therapy opportunities webinar

Hosted by DDW and sponsored by Astrea Bioseparations “Cell and gene therapies – how can market growth be sustained to maximise on opportunities” – will be free to attend on 28 February at 7AM PST / 10AM EST / 3PM GMT / 4PM CET.   Join this… Read More

#News

Miami skyline
#Advanced Therapies #Cell and gene therapy #Drug development #Manufacturing #Viral vectors

What challenges does the advanced therapies sector face? 

Over the three days of Advanced Therapies Week (ATW) 2024 in Miami, Florida, US, 16-19 January 2024, DDW’s Megan Thomas heard from attendees about the obstacles the sector needs to overcome to succeed.   Viral vector manufacturing   At the Advanced Therapies Awards ceremony, Dr Luigi Naldini,… Read More

#Exclusive Content #Opinion #Regulatory

UK
#Advanced Therapies #BioIndustry Association #Cell and gene therapy #Cell and Gene Therapy Catapult #UK

UK maintains dominant global position in cell and gene therapy

The UK is cementing its position as a global leader in cell and gene therapy (CGT), according to a new report released today by the UK BioIndustry Association (BIA), in collaboration with Citeline. The report reveals a robust sector with significant investment, the highest number of… Read More

#News #Trending News

#Advanced Therapies #CAR-T #Cell and gene therapy #Cell therapy #Drug discovery #eBook #Gene therapy

DDW eBook: The latest innovations in cell and gene therapy

Hailed as a revolution in the treatment of many diseases, cell and gene therapy is the fastest growing area of therapeutics. This eBook, ‘Cell & Gene Therapy: The advances and innovation’, provides a comprehensive overview of the latest innovations in cell and gene therapies, where the… Read More

#News

#Advanced Therapies #CAR-T #Cell and gene therapy #Cell therapy #Drug discovery #eBook #Gene therapy

Cell & Gene Therapy: The advances and innovation

This 24-page eBook sponsored by Sartorius explores the latest innovations in cell and gene therapies, where the challenges lie and the possible solutions to overcoming these obstacles. Download this free resource to learn more about: The ways cell and gene therapies (CGTs) are revolutionising medicine in a range of diseases How… Read More

#DDW eBooks #Intelligence

Scotland flag
#Advanced Therapies #CGT Catapult #Drug development #Scotland

UK network launches to boost advanced therapies in the north  

A new cooperative network designed to foster collaboration and boost the sharing of knowledge and expertise for the UK’s advanced therapies sector has been launched.  The ‘Scottish Advanced Therapy Medicinal Products (ATMP) and Vaccines Network’ specifically targets researchers in the north of the UK… Read More

#News

Cell and gene therapies
#Advanced Therapies #Advanced Therapies Europe #Cell and gene therapy #Cell therapy #Gene therapy

Advanced Therapies Europe: From bench to bedside and boardroom

Advanced Therapies Europe took place from 9-12 September 2023 in Portugal. DDW’s Megan Thomas asked attendees: What is most important to scale from discovery to commercialisation of cell and gene therapies (CGTs)? Joel Eichmann, Co-Founder, Green Elephant Biotech It always comes down to time-to-market and risk… Read More

#Exclusive Content

EU and US flags
#Advanced Therapies #Cell and gene therapy #EMA #FDA #Regulatory

Overcoming diverging regulatory expectations to bring CGTs to market

Lung-I Cheng, Vice President and Head of Cell & Gene Therapy Service Line at AmerisourceBergen, and Cori Gorman, Senior Director of CMC and Regulatory Affairs at Biopharma Excellence, offer advice on navigating the different and sometimes contradictory regulatory requirements in the US and EU. Over the… Read More

#Exclusive Content #Regulatory #Trends & Analysis

Advanced therapies
#Advanced Therapies #CAR-T #Cell and gene therapy #Drug development

Commercialising advanced therapies: Industry perspectives 

Dr Christian K Schneider, Head of Biopharma Excellence at PharmaLex, presents the findings of an industry panel debate on barriers to commercialisation of novel treatments, and the most effective strategies to bring them to market.  With so many exciting novel treatments emerging from the labs, biotechs and pharma companies… Read More

#Exclusive Content #Opinion